![Mark Brister](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark Brister worked as a VP-Research & Development, Operations Director, Vice President-Vascular Research & Development, and Vice President-Research & Development at Arterial Vascular Engineering, Inc., Medtronic, Inc., and DexCom, Inc. respectively.
He also worked as a Vice President-Research & Development at Obalon Therapeutics, Inc.
Ehemalige bekannte Positionen von Mark Brister
| Unternehmen | Position | Ende |
|---|---|---|
| DEXCOM, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care | Corporate Officer/Principal | 01.01.2003 |
Arterial Vascular Engineering, Inc.
 Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Makes a variety of stent systems and balloon angioplasty catheters | Geschäftsführer | 01.01.1999 |
| VYOME HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care | Health Technology |
Arterial Vascular Engineering, Inc.
Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Makes a variety of stent systems and balloon angioplasty catheters | Health Technology |
Obalon Therapeutics, Inc.
 Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical balloon technology for weight loss therapy | Health Technology |
DexCom, Inc.
 DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
Wählen Sie MarketScreener 
